PDE4 inhibitors for the treatment of neoplasms of lymphoid cells

Details for Australian Patent Application No. 2004204355 (hide)

Owner Nycomed GmbH

Inventors Garattini, Enrico; Hatzelmann, Armin; Schudt, Christian; Sanders, Karl; Tenor, Hermann; Braunger, Jurgen; Gekeler, Volker

Agent Griffith Hack

Pub. Number AU-B-2004204355

PCT Pub. Number WO2004/062671

Priority 03000787.6 14.01.03 EP

Filing date 14 January 2004

Wipo publication date 29 July 2004

Acceptance publication date 17 December 2009

International Classifications

A61K 31/502 (2006.01) - ortho- or peri-condensed with carbocyclic ring systems, e.g. cinnoline, phthalazine

A61K 31/00 (2006.01)

A61K 45/06 (2006.01) Medicinal preparations containing active ingredients not provided for in groups

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

Event Publications

25 August 2005 PCT application entered the National Phase

  PCT publication WO2004/062671 Priority application(s): WO2004/062671

22 November 2007 Change of Name(s) of Applicant(s), Section 104

  ALTANA Pharma AG The name of the applicant has been changed to Nycomed GmbH

17 December 2009 Application Accepted

  Published as AU-B-2004204355

29 April 2010 Standard Patent Sealed

11 August 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004204358-Acylated 4-amidinoand 4-guanidinobenzylamines for the inhibition of plasma kallikrein

2004204353-Pharmaceutical combination for the prophylaxis or treatment of cardiovascular, cardiopulmonary, pulmonary or renal diseases